Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Ultragenyx Pharmaceutical Inc. Transaction History
Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main
- $83.4 Billion
- Q1 2025
A detailed history of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main holds 311,101 shares of RARE stock, worth $11.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
311,101
Previous 346,597
10.24%
Holding current value
$11.4 Million
Previous $14.6 Million
22.75%
% of portfolio
0.01%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$365 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$205 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$152 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$118 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$95.6 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.56B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...